计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
T408478-1ml |
1ml |
现货 ![]() |
|
英文别名 | 6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine |
---|---|
规格或纯度 | Moligand™, 10mM in DMSO |
英文名称 | TG100-115 |
生化机理 | TG100-115 是一种 PI3Kγ/δ 抑制剂,IC50 为 83 nM/235 nM,对 PI3Kα/β 几乎没有影响。1/2阶段。 |
储存温度 | -80℃储存 |
运输条件 | 超低温冰袋运输 |
作用类型 | 抑制剂 |
作用机制 | PI3 激酶 p110-delta 亚基抑制剂 |
产品介绍 |
TG100-115是PI3K γ和δ抑制剂,IC50分别为83和235 nM。A PI3K and FRAP inhibitor with some action against Akt Information TG100-115 is aPI3Kγ/δinhibitor withIC50of 83 nM/235 nM, with little effect on PI3Kα/β. Phase 1/2. TG100-115 inhibits PI3Kγ and -δ, with IC50 of 83 and 235 nM, respectively. TG100-115 is not active for PI3Kα and -β, with IC50 of 1.2 and 1.3 mM. In human umbilical vein endothelial cells (HUVECs), TG100-115 (up to 10 μM) has no effects on cell proliferation and VEGF-stimulated ERK phosphorylation. However, TG100-115 (10 μM) interrupts other VEGF signaling pathways, such as those that culminate in VE-cadherin phosphorylation. In HUVECs, TG100-115 (10 μM) inhibits the VEGF-induced increase of total level of VE-cadherin. TG100-115 inhibits VEGF mediated phosphorylation of mTOR and p70S6 kinase, both of which are downstream of PI3K. TG100-115 (125 nM to 10 μM) also inhibits FGF-stimulated phosphorylation of Akt. In vivo In Miles assay models, TG100-115 (1-5 mg/kg) reduces edema formation and inflammation in rats. In rigorous rodent and porcine models of myocardial ischemia (MI), TG100-115 (0.5-5 mg/kg) provides potent cardioprotection, limits infarct development, and preserves myocardial function. In mice, TG100-115 (5 mg/kg) markedly diminishes vascular permeability (VP) in response to either Sema3A or VEGF, indicating that both factors may depend on PI3Kγ/δ to induce VP. In a mouse asthma model, aerosolized TG100-115 markedly reduces the pulmonary eosinophilia, inhibits interleukin-13 and mucin accumulation. cell lines: Concentrations:10 μM, dissolved in DMSO as stock solution Incubation Time:24, 48, and 72 hours Powder Purity:≥99% |
IC50 | PI3Kδ, IC50: 235 nM |
---|
分子类型 | 小分子 |
---|---|
Canonical SMILES | NC1=NC2=NC(=C(N=C2C(=N1)N)C3=CC(=CC=C3)O)C4=CC=CC(=C4)O |
分子量 | 346.34 |
溶解性 | Solubility (25°C) In vitro DMSO: 92 mg/mL (199.37 mM); Water: Insoluble; Ethanol: Insoluble; |
---|
Concentration | 9-11(mmol/L) |
---|---|
Proton NMR spectrum | Conforms to Structure |